Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Panel Calls For Outcomes Data On Non-Invasive Coronary Imaging

This article was originally published in The Gray Sheet

Executive Summary

More evidence is needed to support the value of non-invasive imaging techniques such as computer tomographic angiography (CTA) in making a diagnosis or prognosis for coronary artery disease, CMS' Medicare Coverage Advisory Committee concluded during a May 18 meeting

You may also be interested in...



Imaging Makers Hit The Hill To Protect Cardiac CT Angiography Coverage

Imaging system manufacturers hope Congress can help convince CMS to backtrack on a proposed national coverage policy they say will block use of computed tomography imaging for coronary angiography

Imaging Makers Hit The Hill To Protect Cardiac CT Angiography Coverage

Imaging system manufacturers hope Congress can help convince CMS to backtrack on a proposed national coverage policy they say will block use of computed tomography imaging for coronary angiography

CMS Analyzing National Coverage Of Computed Tomographic Angiography

CMS is considering whether high resolution, high speed computed tomography should be nationally covered for diagnosing coronary artery disease in Medicare patients

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023576

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel